Insider Selling: Cryoport, Inc. (NASDAQ:CYRX) CEO Sells 2,631 Shares of Stock

Cryoport, Inc. (NASDAQ:CYRX) CEO Jerrell Shelton sold 2,631 shares of Cryoport stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $17.54, for a total value of $46,147.74. Following the completion of the sale, the chief executive officer now directly owns 692,182 shares in the company, valued at approximately $12,140,872.28. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Jerrell Shelton also recently made the following trade(s):

• On Monday, March 11th, Jerrell Shelton sold 3,723 shares of Cryoport stock. The shares were sold at an average price of $16.35, for a total value of $60,871.05.
• On Friday, March 15th, Jerrell Shelton sold 57,039 shares of Cryoport stock. The shares were sold at an average price of $15.30, for a total value of $872,696.70.

Cryoport Price Performance

NASDAQ:CYRX opened at $18.12 on Thursday. The company has a quick ratio of 11.16, a current ratio of 11.73 and a debt-to-equity ratio of 0.82. The stock’s 50 day moving average price is $15.95 and its two-hundred day moving average price is $14.37. The firm has a market capitalization of $887.52 million, a price-to-earnings ratio of -8.24 and a beta of 1.61. Cryoport, Inc. has a 12-month low of $9.00 and a 12-month high of $24.30.

Wall Street Analyst Weigh In

CYRX has been the topic of several analyst reports. Stephens reiterated an “equal weight” rating and set a $17.00 target price on shares of Cryoport in a report on Wednesday, March 13th. UBS Group upped their target price on Cryoport from $14.50 to $17.00 and gave the stock a “neutral” rating in a report on Friday, March 15th. Finally, Needham & Company LLC dropped their target price on Cryoport from $19.00 to $18.00 and set a “buy” rating on the stock in a report on Wednesday, March 13th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $18.29.

Institutional Trading of Cryoport

Institutional investors and hedge funds have recently bought and sold shares of the business. Nordea Investment Management AB bought a new stake in Cryoport in the third quarter valued at approximately $1,153,000. Connor Clark & Lunn Investment Management Ltd. raised its stake in Cryoport by 285.9% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 77,409 shares of the company’s stock valued at $1,061,000 after buying an additional 57,348 shares during the period. Assenagon Asset Management S.A. bought a new stake in Cryoport in the third quarter valued at approximately $3,250,000. WCM Investment Management LLC raised its stake in Cryoport by 2.0% in the third quarter. WCM Investment Management LLC now owns 299,984 shares of the company’s stock valued at $4,113,000 after buying an additional 5,839 shares during the period. Finally, Massachusetts Financial Services Co. MA raised its stake in Cryoport by 28.3% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,356,500 shares of the company’s stock valued at $18,598,000 after buying an additional 298,995 shares during the period. Institutional investors own 92.90% of the company’s stock.

Cryoport Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.